5 completed, 1 terminated, 1 unknown. 2 Not applicable, 2 Phase 4, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 2 |
| Phase 4 | 2 | Completed 1, Terminated 1 |
| Phase 2 | 1 | Unknown 1 |
| Phase 3 | 1 | Completed 1 |
Follow Instituto Fernandes Figueira: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Immunogenicity and Safety of Heterologous and Homologous Boosting With ChAdOx1-S and CoronaVac or a Formulation of SCB-2019 (COVID-19) ChAdOx1-S COVID-19 Vaccine(Fiocruz/Oxford-AstraZeneca), CoronaVac (Sinovac Biotech), Adjuvanted Recombinant SARS-CoV-2 TrimericS-protein Subunit Vaccine (SCB-2019 - Clover) - Covid19 | Phase 2 | Unknown | D'Or Institute for Research and Education | 520 | 2021-12-01 | 2021-10-21 |
| Smoking Cessation in a Cohort HIV+ Rio de Janeiro, Brazil. Nicotine replacement - Smoking Cessation, Brachial Flow Mediated Dilatation | Completed | Instituto Fernandes Figueira | 115 | 2019-12-10 | 2023-05-24 | |
| Post ExpOsure Prophylaxis for LEprosy in the Comoros and Madagascar Rifampicin - Leprosy | Phase 3 | Completed | Institute of Tropical Medicine, Belgium | 144000 | 2019-01-02 | 2025-03-04 |
| Calcium-vitamin D & Periodontal Therapy for Improving Metabolic and Inflammatory Profile Among Pregnant Women Early PT, Delayed PT, Fortified Milk - Periodontitis, Inflammation | Not applicable | Completed | University of Westminster | 70 | 2017-04-24 | 2021-08-03 |
| PREPARE, Prematurity Reduction by Pre-eclampsia Care FullPIERS and sFlit/PLGF (Soluble fms-Like Tyrosine Kinase-1-to-Placental Growth Factor Ratio) - Pre-Eclampsia, Premature Birth | Not applicable | Completed | Instituto Fernandes Figueira | 1250 | 2016-12-01 | 2023-07-18 |
| Sucking Pattern of Preterm Infants Using Cup or Bottle Before Breastfeeding cup feeding, bottle feeding - Infant, Very Low Birth Weight | Phase 4 | Terminated | Instituto Fernandes Figueira | 56 | 2008-01-01 | 2015-08-11 |
| Efficacy of High-dose Intravenous Immunoglobulin Therapy for Hyperbilirubinemia Due Rh Hemolytic Disease Intravenous Immunoglobulin, Normal saline solution - Hyperbilirubinemia, Erythroblastosis, Fetal | Phase 4 | Completed | Oswaldo Cruz Foundation | 92 | 2006-10-01 | 2016-01-08 |
Breast Feeding (1) · COVID-19 (1) · Erythroblastosis, Fetal (1) · Hyperbilirubinemia (1) · Inflammation (1) · Leprosy (1) · Perinatal Death (1) · Periodontitis (1) · Pre-Eclampsia (1) · Premature Birth (1) · Smoking Cessation (1)
Immunoglobulins (1) · Immunoglobulins, Intravenous (1) · Nicotine Replacement Therapy (1) · Rifampin (1) · Saline Solution (1) · sinovac COVID-19 vaccine (1)
Brazil (6) · Comoros (1) · Madagascar (1)
Bertrand Cauchoix, MD (1) · Bouke de Jong, MD, PhD (1) · Epco Hasker, MD (1) · Marcos A Dias, PhD (1) · Maria EL Moreira, MD (1) · Younoussa Assoumani, MD (1)
PMID 11879422, PMID 12908998, PMID 15947178, PMID 16829207, PMID 17092344, PMID 19070896, PMID 19265049, PMID 20482822, PMID 20733449, PMID 21185591, PMID 22882285, PMID 23741776, PMID 23906160, PMID 23927768, PMID 23954534, PMID 24215470, PMID 25861796, PMID 26735990, PMID 30873290, PMID 31590640, PMID 31805862, PMID 32138765, PMID 35850123, PMID 36043184, PMID 37431663, PMID 38762282